EARNEST Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $164M | Sell |
588,731
-14,863
| -2% | -$4.28M | 0.68% | 49 |
|
|
2025
Q4 | $183M | Sell |
603,594
-5,690
| -0.9% | -$1.78M | 0.78% | 36 |
|
|
2025
Q3 | $171M | Buy |
609,284
+3,398
| +0.6% | +$925K | 0.74% | 38 |
|
|
2025
Q2 | $146M | Buy |
605,886
+6,265
| +1% | +$1.48M | 0.66% | 52 |
|
|
2025
Q1 | $146M | Sell |
599,621
-18,428
| -3% | -$5.54M | 0.7% | 45 |
|
|
2024
Q4 | $203M | Buy |
618,049
+12,500
| +2% | +$4.24M | 0.91% | 25 |
|
|
2024
Q3 | $203M | Sell |
605,549
-1,239
| -0.2% | -$394K | 0.88% | 28 |
|
|
2024
Q2 | $166M | Buy |
606,788
+91,882
| +18% | +$26.7M | 0.77% | 38 |
|
|
2024
Q1 | $178M | Buy |
514,906
+121,272
| +31% | +$39.9M | 0.82% | 34 |
|
|
2023
Q4 | $127M | Buy |
393,634
+42,124
| +12% | +$13.2M | 0.63% | 55 |
|
|
2023
Q3 | $126M | Buy |
351,510
+71,570
| +26% | +$27.6M | 0.73% | 44 |
|
|
2023
Q2 | $106M | Buy |
279,940
+26,476
| +10% | +$10.8M | 0.59% | 65 |
|
|
2023
Q1 | $121M | Buy |
253,464
+8,519
| +3% | +$3.99M | 0.7% | 46 |
|
|
2022
Q4 | $103M | Buy |
244,945
+14,265
| +6% | +$5.76M | 0.63% | 63 |
|
|
2022
Q3 | $96.2M | Buy |
230,680
+6,464
| +3% | +$3.22M | 0.65% | 61 |
|
|
2022
Q2 | $111M | Buy |
224,216
+32,275
| +17% | +$16.8M | 0.74% | 48 |
|
|
2022
Q1 | $108M | Buy |
191,941
+1,360
| +0.7% | +$820K | 0.64% | 63 |
|
|
2021
Q4 | $144M | Buy |
190,581
+18,419
| +11% | +$13.8M | 0.83% | 41 |
|
|
2021
Q3 | $128M | Sell |
172,162
-2,257
| -1% | -$1.69M | 0.78% | 44 |
|
|
2021
Q2 | $112M | Buy |
174,419
+7,410
| +4% | +$4.51M | 0.66% | 59 |
|
|
2021
Q1 | $95.4M | Buy |
167,009
+15,547
| +10% | +$9.21M | 0.57% | 68 |
|
|
2020
Q4 | $88.3M | Buy |
151,462
+8,286
| +6% | +$4.72M | 0.61% | 69 |
|
|
2020
Q3 | $73.8M | Buy |
143,176
+10,780
| +8% | +$5.46M | 0.64% | 65 |
|
|
2020
Q2 | $59.8M | Buy |
132,396
+8,558
| +7% | +$3.78M | 0.56% | 78 |
|
|
2020
Q1 | $43.4M | Buy |
123,838
+2,872
| +2% | +$1.06M | 0.49% | 86 |
|
|
2019
Q4 | $44.8M | Buy |
120,966
+12,889
| +12% | +$4.54M | 0.35% | 104 |
|
|
2019
Q3 | $36M | Buy |
108,077
+174
| +0.2% | +$56.8K | 0.32% | 103 |
|
|
2019
Q2 | $33.7M | Buy |
107,903
+5,111
| +5% | +$1.53M | 0.3% | 112 |
|
|
2019
Q1 | $31.4M | Sell |
102,792
-1,626
| -2% | -$439K | 0.3% | 113 |
|
|
2018
Q4 | $24.2M | Buy |
104,418
+164
| +0.2% | +$44K | 0.26% | 120 |
|
|
2018
Q3 | $32.6M | Sell |
104,254
-2,471
| -2% | -$767K | 0.29% | 112 |
|
|
2018
Q2 | $30.8M | Sell |
106,725
-2,332
| -2% | -$644K | 0.29% | 111 |
|
|
2018
Q1 | $27.3M | Sell |
109,057
-250
| -0.2% | -$63.7K | 0.26% | 116 |
|
|
2017
Q4 | $26.1M | Sell |
109,307
-5,464
| -5% | -$1.32M | 0.25% | 117 |
|
|
2017
Q3 | $25.5M | Sell |
114,771
-2,458
| -2% | -$553K | 0.25% | 112 |
|
|
2017
Q2 | $26.5M | Sell |
117,229
-6,367
| -5% | -$1.39M | 0.28% | 107 |
|
|
2017
Q1 | $24.6M | Sell |
123,596
-1,730
| -1% | -$333K | 0.26% | 112 |
|
|
2016
Q4 | $22.8M | Sell |
125,326
-5,646
| -4% | -$963K | 0.25% | 122 |
|
|
2016
Q3 | $21.5M | Sell |
130,972
-2,727
| -2% | -$414K | 0.23% | 130 |
|
|
2016
Q2 | $19.1M | Sell |
133,699
-2,157
| -2% | -$308K | 0.21% | 130 |
|
|
2016
Q1 | $18.6M | Buy |
135,856
+816
| +0.6% | +$107K | 0.19% | 130 |
|
|
2015
Q4 | $18.7M | Sell |
135,040
-3,131
| -2% | -$434K | 0.19% | 128 |
|
|
2015
Q3 | $18.6M | Sell |
138,171
-15,808
| -10% | -$2.28M | 0.18% | 132 |
|
|
2015
Q2 | $23.2M | Sell |
153,979
-2,505
| -2% | -$358K | 0.2% | 131 |
|
|
2015
Q1 | $21.2M | Sell |
156,484
-5,008
| -3% | -$621K | 0.18% | 139 |
|
|
2014
Q4 | $19.5M | Sell |
161,492
-6,398
| -4% | -$736K | 0.16% | 146 |
|
|
2014
Q3 | $19M | Sell |
167,890
-4,599
| -3% | -$545K | 0.16% | 148 |
|
|
2014
Q2 | $20.6M | Sell |
172,489
-4,948
| -3% | -$604K | 0.16% | 146 |
|
|
2014
Q1 | $22.7M | Buy |
177,437
+498
| +0.3% | +$63.8K | 0.18% | 138 |
|
|
2013
Q4 | $21.9M | Buy |
+176,939
| New | +$21.6M | 0.18% | 143 |
|
Other funds holding BIO
VCM
VPM
AI
